AMAG Pharma announces definitive agreement to acquire Perosphere Pharmaceuticals
AMAG Pharmaceuticals announced a definitive agreement to acquire Perosphere Pharmaceuticals. AMAG will pay Perosphere equity holders $50 million and will assume $12 million under a term loan and up to $6.2 million of Perosphere’s other liabilities. December 13, 2018